MAIN OUTCOME MEASURES: The primary outcome measures were prevalence rates of the above-mentioned side effects. RESULTS: Overall, 316 questionnaires were available for analyses. Of the sexually active patients (n = 256), 12 (5%) reported anorgasmia, whereas 153 (60%) reported decreased orgasm intensity. 